TY - JOUR
T1 - Quantity and Quality of Naturally Acquired Antibody Immunity to the Pneumococcal Proteome Throughout Life
AU - Vissers, Marloes
AU - van de Garde, Martijn D. B.
AU - He, Samantha W. J.
AU - Brandsen, Milou
AU - Hendriksen, Rosanne
AU - Nicolaie, Mioara Alina
AU - van der Maas, Larissa
AU - Meiring, Hugo D.
AU - van Els, Cecile A. C. M.
AU - van Beek, Josine
AU - Rots, Nynke Y.
N1 - Publisher Copyright:
© 2024 The Author(s). Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved.
PY - 2024/12/15
Y1 - 2024/12/15
N2 - Background: Young children and older adults are susceptible for invasive pneumococcal disease (IPD) caused by Streptococcus pneumoniae. Pneumococcal protein-specific antibodies play a protective role against IPD; however, not much is known about the pace of acquisition, maturation, and maintenance of these antibodies throughout life. Methods: Immunoglobulin G (IgG) and IgA levels, avidity, and/or specificity to the pneumococcal proteome in serum and saliva from healthy young children, adults, and older adults, with known carriage status, were measured by enzyme-linked immunosorbent assay (ELISA) and 2-dimensional western blotting against ΔcpsTIGR4. Results: Eleven-month-old children, the youngest age group tested, had the lowest pneumococcal proteome-specific IgG and IgA levels and avidity in serum and saliva, followed by 24-month-old children and were further elevated in adult groups. Among adult groups, the parents had the highest serum and saliva IgG and IgA antibody levels. In children, antibody levels and avidity correlated with daycare attendance and presence of siblings, posing as proxy for exposure and immunization. Immunodominance patterns slightly varied throughout life. Conclusions: Humoral immunity against the pneumococcal proteome is acquired through multiple episodes of pneumococcal exposure. Low-level and low-avidity antiproteome antibody profiles in young children may contribute to their IPD susceptibility, while in overall antiproteome antibody-proficient older adults other factors likely play a role.
AB - Background: Young children and older adults are susceptible for invasive pneumococcal disease (IPD) caused by Streptococcus pneumoniae. Pneumococcal protein-specific antibodies play a protective role against IPD; however, not much is known about the pace of acquisition, maturation, and maintenance of these antibodies throughout life. Methods: Immunoglobulin G (IgG) and IgA levels, avidity, and/or specificity to the pneumococcal proteome in serum and saliva from healthy young children, adults, and older adults, with known carriage status, were measured by enzyme-linked immunosorbent assay (ELISA) and 2-dimensional western blotting against ΔcpsTIGR4. Results: Eleven-month-old children, the youngest age group tested, had the lowest pneumococcal proteome-specific IgG and IgA levels and avidity in serum and saliva, followed by 24-month-old children and were further elevated in adult groups. Among adult groups, the parents had the highest serum and saliva IgG and IgA antibody levels. In children, antibody levels and avidity correlated with daycare attendance and presence of siblings, posing as proxy for exposure and immunization. Immunodominance patterns slightly varied throughout life. Conclusions: Humoral immunity against the pneumococcal proteome is acquired through multiple episodes of pneumococcal exposure. Low-level and low-avidity antiproteome antibody profiles in young children may contribute to their IPD susceptibility, while in overall antiproteome antibody-proficient older adults other factors likely play a role.
KW - Aging
KW - Avidity
KW - Carriage
KW - Humoral immunity
KW - IgA
KW - IgG
KW - Pneumococcal proteins
KW - Pneumococcal-specific antibodies
KW - S. pneumoniae
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=d7dz6a2i7wiom976oc9ff2iqvdhv8k5x&SrcAuth=WosAPI&KeyUT=WOS:001248971000001&DestLinkType=FullRecord&DestApp=WOS_CPL
U2 - 10.1093/infdis/jiae255
DO - 10.1093/infdis/jiae255
M3 - Article
C2 - 38888894
SN - 0022-1899
VL - 230
SP - 1466
EP - 1475
JO - Journal of Infectious Diseases
JF - Journal of Infectious Diseases
IS - 6
ER -